Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Mycosis Fungoides 5Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Keratosis, Actinic 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Stomach Neoplasms 1Sleep Wake Disorders 1Pleural Diseases 1Peptic Ulcer 1Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Hematologic Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Phototherapy × Clear all
NCT07628894 2026-06-05

Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy

City of Hope Medical Center

Phase 1 Not yet recruiting
8 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡